In a cross-sectional analysis of 33 cases of breast cancer diagnosed in female relatives of 99 AT families in the USA, in which gene mutations were analysed, Athma et al (1996) found a significantly increased odds ratio of 3.8 for breast cancer among ATM gene carriers compared with noncarriers. This evidence concerns the gene ATM and breast carcinoma.